Position in RPRX
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$31,232,559
+$10,352,802 QoQ
Shares Held
557,028
+28.0% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#5
of 107 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Handelsbanken Fonder AB holds $686,434,691 across 88 Biotechnology names. RPRX ranks #9 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
218,292 | $108,432,185 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
631,899 | $49,458,734 | |
| 3 | ARGX |
Argenx SE
|
52,653 | $48,849,873 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
212,275 | $39,754,862 | |
| 5 | CYTK |
Cytokinetics Inc
|
405,000 | $34,501,950 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
90,407 | $33,601,569 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,328 | $32,628,601 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
107,255 | $32,286,972 |
All Filings in RPRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,232,559 | 557,028 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $20,879,757 | 435,267 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $12,198,107 | 315,686 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $9,159,570 | 259,625 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,123,084 | 253,208 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,494,481 | 433,488 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $11,739,268 | 460,183 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $20,406,340 | 721,327 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $18,855,314 | 715,029 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $20,691,111 | 681,301 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $25,053,976 | 891,918 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $25,284,601 | 931,636 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $24,325,668 | 791,336 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $25,420,390 | 705,534 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $24,125,102 | 610,453 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $5,581,002 | 138,900 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $2,068,368 | 49,200 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,659,696 | 42,600 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,346,930 | 33,800 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,221,532 | 33,800 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $610,751 | 14,900 | Shares | Sole | 2021-08-03 | |
| 2020-12-31 | $407,607 | 8,144 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||